NASDAQ:GRPH Graphite Bio (GRPH) Stock Price, News & Analysis → Time is Running Out - June 25th Deadline Approaching! (From Paradigm Press) (Ad) Free GRPH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$3.05▼$3.2350-Day Range$3.18▼$26.1152-Week Range$2.01▼$4.26Volume328,300 shsAverage Volume282,405 shsMarket Capitalization$185.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisDividendEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsStock AnalysisDividendEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Get Graphite Bio alerts: Email Address Ad Paradigm PressI’m a Crypto Millionaire. Here’s Why I Sold ALL My Bitcoin…Bitcoin can and probably will hit the $1 MILLION level this decade. That’s more than 1,000% upside from these levels.But there are at least 10 different coins that I like even better. About Graphite Bio Stock (NASDAQ:GRPH)Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. The company offers GPH102 for the treatment of beta-thalassemia; and GPH201 for the treatment of XSCID, a life-threatening disease for multiple mutations in a single gene. It also offers GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is based in South San Francisco, California.Read More Ad Paradigm PressI’m a Crypto Millionaire. Here’s Why I Sold ALL My Bitcoin…Bitcoin can and probably will hit the $1 MILLION level this decade. That’s more than 1,000% upside from these levels.But there are at least 10 different coins that I like even better. GRPH Stock News HeadlinesMay 16, 2024 | benzinga.comVersant Vantage II, L.P.'s Net WorthMarch 21, 2024 | finance.yahoo.comLENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate ProgressMarch 15, 2024 | finance.yahoo.comGRPH Mar 2024 5.000 putMarch 15, 2024 | seekingalpha.comVERI, STI and VERB among mid-day moversMarch 15, 2024 | finance.yahoo.comGRPH Mar 2024 7.500 callMarch 14, 2024 | finance.yahoo.comGraphite Bio, Inc. (GRPH)March 10, 2024 | marketwatch.comGraphite Bio to Pay Special Dividend Linked to Lenz Therapeutics MergerMarch 8, 2024 | au.investing.comGraphite Bio announces $1.03 per share special dividendMarch 8, 2024 | msn.comGraphite Bio declares special $1.03 dividendMarch 8, 2024 | businesswire.comGraphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz TherapeuticsFebruary 27, 2024 | businesswire.comGRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPHFebruary 2, 2024 | markets.businessinsider.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Graphite Bio, Inc. (GRPH)December 25, 2023 | seekingalpha.comGraphite Bio: Reverse Merger Leading Into Big Special Dividend And Q2 Phase 3 TrialNovember 27, 2023 | msn.comGraphite Bio (GRPH) Price Target Increased by 40.00% to 7.14November 17, 2023 | businesswire.comGRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPHNovember 17, 2023 | businesswire.comGRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPHNovember 16, 2023 | benzinga.comShareholder Alert: Ademi LLP investigates whether Graphite Bio, Inc. has obtained a Fair Price in its transaction with LENZ TherapeuticsNovember 16, 2023 | bizjournals.comShattered dream of sickle cell disease cure to end in reverse merger for Peninsula biotechNovember 16, 2023 | finance.yahoo.comWhat Makes Graphite Bio, Inc. (GRPH) a New Buy StockNovember 15, 2023 | benzinga.comGRPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Graphite Bio, Inc. Is Fair to ShareholdersNovember 15, 2023 | markets.businessinsider.comGraphite Bio To Merge With LENZ Therapeutics; Stock Down In Pre-marketNovember 15, 2023 | finance.yahoo.comLENZ Therapeutics and Graphite Bio Announce Merger AgreementNovember 9, 2023 | morningstar.comGraphite Bio Inc GRPHNovember 1, 2023 | msn.comGraphite Bio (GRPH) Price Target Increased by 25.00% to 5.10October 5, 2023 | msn.comGraphite Bio (GRPH) Price Target Increased by 11.11% to 4.08See More Headlines Receive GRPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Graphite Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/20/2023Ex-Dividend for 3/21 Dividend3/15/2024Dividend Payable3/21/2024Today6/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:GRPH CUSIPN/A CIK1815776 Webwww.graphitebio.com Phone650-484-0886FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.23) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-124,650,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-33.12% Return on Assets-27.96% Debt Debt-to-Equity RatioN/A Current Ratio39.20 Quick Ratio39.20 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$3.15 per share Price / Book1.01Miscellaneous Outstanding Shares58,240,000Free Float35,874,000Market Cap$185.20 million OptionableNot Optionable Beta0.20 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesDr. Matthew Porteus M.D. (Age 58)Ph.D., Academic Founder & Director Comp: $110kStephanie YaoVice President of Communications & Investor RelationsDr. Christine Garrett P.M.P. (Age 53)Ph.D., Chief Strategy Officer Key CompetitorsSangamo TherapeuticsNASDAQ:SGMObluebird bioNASDAQ:BLUEAVROBIONASDAQ:AVROAtea PharmaceuticalsNASDAQ:AVIRFreeline TherapeuticsNASDAQ:FRLNView All Competitors GRPH Stock Analysis - Frequently Asked Questions How were Graphite Bio's earnings last quarter? Graphite Bio, Inc. (NASDAQ:GRPH) released its quarterly earnings data on Monday, March, 20th. The company reported ($3.08) earnings per share for the quarter, topping the consensus estimate of ($3.43) by $0.35. How often does Graphite Bio pay dividends? What is the dividend yield for Graphite Bio? Graphite Bio announced a dividend on Friday, March 15th. Shareholders of record on Monday, March 18th will be paid a dividend of $7.21 per share on Thursday, March 21st. This represents a dividend yield of 28.93%. The ex-dividend date of this dividend is Friday, March 15th. Read our dividend analysis for GRPH. When did Graphite Bio's stock split? Shares of Graphite Bio reverse split on Friday, March 22nd 2024. The 1-7 reverse split was announced on Friday, March 22nd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, March 22nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split. When did Graphite Bio IPO? Graphite Bio (GRPH) raised $224 million in an initial public offering on Friday, June 25th 2021. The company issued 14,000,000 shares at a price of $15.00-$17.00 per share. This page (NASDAQ:GRPH) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s...Weiss Ratings | SponsoredMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Graphite Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Graphite Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.